These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5118688)

  • 1. Cytosine arabinoside (NSC-63878) in the treatment of epidermoid carcinomas of the head and neck.
    Papac RJ; Fischer JJ
    Cancer Chemother Rep; 1971 Apr; 55(2):193-7. PubMed ID: 5118688
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
    Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
    Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
    Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
    [No Abstract]   [Full Text] [Related]  

  • 5. Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas.
    Lefkowitz E; Papac RJ; Bertino JR
    Cancer Chemother Rep; 1967 Sep; 51(5):305-11. PubMed ID: 4863189
    [No Abstract]   [Full Text] [Related]  

  • 6. Porfiromycin in the management of epidermoid and transitional cell cancer: a phase II study.
    Panettiere FJ; Talley RW; Torres J; Lane M
    Cancer Treat Rep; 1976 Jul; 60(7):907-11. PubMed ID: 795539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of cis-platinum-bleomycin therapy.
    Najarian T; Miller A; Zimelman AP; Ki Hong W
    Oncology; 1981; 38(4):195-7. PubMed ID: 6165944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
    Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study.
    Jelic S; Mitrovic L; Kovcin V; Nikolic-Tomasevic Z; Radulovic S; Tomasevic Z; Popov I
    J Chemother; 1996 Aug; 8(4):304-9. PubMed ID: 8873838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL; DeConti RC; Marsh JC; Bertino JR
    Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.
    Creagan ET; Schutt AJ; Ingle JN; O'Fallon JR
    Cancer Treat Rep; 1983 Nov; 67(11):1047. PubMed ID: 6640554
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man.
    Onuma T; Holland JF; Sako K; Shedd DP
    Cancer Chemother Rep; 1972 Oct; 56(5):625-33. PubMed ID: 4119907
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
    Wheeler RH; Bricker LJ; Natale RB; Baker SR
    Cancer Treat Rep; 1984 Feb; 68(2):427-8. PubMed ID: 6421483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
    Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
    Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequential administration of methotrexate and 5-fluorouracil in epidermoid carcinomas of the head and neck. Results of a prospective study].
    Chevallier B; Lefur R; Dehesdin D; Bastit P; Seng SH
    Bull Cancer; 1986; 73(6):680-2. PubMed ID: 3567373
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between hematotoxicity and serum albumin level in the treatment of head and neck cancers with concurrent chemoradiotherapy using cisplatin.
    Ishizuka M; Fujimoto Y; Itoh Y; Kitagawa K; Sano M; Miyagawa Y; Ando A; Hiramatsu M; Hirasawa N; Ishihara S; Nakashima T; Yamada K
    Jpn J Clin Oncol; 2011 Aug; 41(8):973-9. PubMed ID: 21693483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.
    Vogel CL; Comis R; Ziegler JL; Kiryabwire JW
    Cancer Chemother Rep; 1971 Apr; 55(2):143-9. PubMed ID: 5118684
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of pyrazofurin in advanced head and neck cancer.
    Cheng E; Currie V; Wittes RE
    Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.
    Craig JB; Powell BL; Jackson DV; Atkins JN; Smith LR; White DR; Richards F; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):151-3. PubMed ID: 3802112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.